EDITAS MEDICINE INC.
3.1850
07-November-24 12:36:39
15 minutes delayed
Stocks
-0.0950
-2.90%
Today's range
3.1100 - 3.3000
ISIN
N/A
Source
NASDAQ
-
07 Oct 2021 07:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
30 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
-
29 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Emma Reeve to Board of Directors
08 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
07 Sep 2021 15:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Participate in Upcoming Investor Conferences
02 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
-
20 Aug 2021 15:20:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2021 Results and Business Updates
04 Aug 2021 06:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Second Quarter 2021 Results and Corporate Update
28 Jul 2021 06:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Bruce E. Eaton, Ph.D., as Executive Vice President and Chief Business Officer
26 Jul 2021 08:00:00 By Nasdaq GlobeNewswire
-
23 Jun 2021 06:00:00 By Nasdaq GlobeNewswire
-
15 Jun 2021 15:01:00 By Nasdaq GlobeNewswire
-
14 Jun 2021 08:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Announces First Quarter 2021 Results and Update
05 May 2021 06:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer
05 May 2021 05:59:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update
28 Apr 2021 06:01:00 By Nasdaq GlobeNewswire